NEW YORK ( TheStreet) -- Pharmerica Corporation (NYSE: PMC) hit a new 52-week high Thursday as it is currently trading at $15.15, above its previous 52-week high of $14.83 with 173,017 shares traded as of 9:31 a.m. ET. Average volume has been 589,900 shares over the past 30 days.

Pharmerica has a market cap of $426.4 million and is part of the services sector and retail industry. Shares are up 28% year to date as of the close of trading on Wednesday.

PharMerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities and provides management pharmacy services to hospitals. The company has a P/E ratio of 24.2, above the average retail industry P/E ratio of 21.3 and above the S&P 500 P/E ratio of 17.7.
  • Practice your PMC trading strategies and win cash in our stock game.

TheStreet Ratings rates Pharmerica as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and poor profit margins. You can view the full Pharmerica Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Private Briefing: KKR's Healthcare Deal Spree

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

13 Things Kentucky Is Best Known for Other Than the Kentucky Derby

PharMerica (PMC) Stock Soars, Exploring Possible Sale